A Cost-Effectiveness Model of Tibolone as Treatment for the Prevention of Osteoporotic Fractures in Postmenopausal Women in Sweden

Author： Willis M.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.21, Iss.2, 2001-02, pp. : 115-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women

By Hiligsmann Mickaël   Boonen Annelies   Dirksen Carmen D   Sedrine Wafa Ben   Reginster Jean-Yves  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 1, 2013-02 ,pp. : 19-28

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis

By Rosner A.J.  

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 559-573

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium

By Hiligsmann Mickaël   Reginster Jean-Yves  

PharmacoEconomics, Vol. 29, Iss. 10, 2011-10 ,pp. : 895-911

Adis International

Access to resources Recommend Favorite

Tibolone: additional cost negligible in postmenopausal women

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 295, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Tibolone: additional cost negligible in postmenopausal women

By  

Inpharma, Vol. 1, Iss. 1270, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite